| WT |
cohort |
6 |
3 |
WT sham, wild type, wild type mice, wild-type, wild-type mice |
| WTCCC |
cohort |
13 |
7 |
WTCCC, WTCCC Crohn's disease data, Wellcome Trust Case Control Consortium |
| WTCCC2 |
cohort |
5 |
3 |
WTCCC2 SNPs, WTCCC2 analysis, WTCCC2 controls, WTCCC2 experiment, Wellcome Trust Case Control Consortium 2 |
| Wy-14,643 |
drug |
3 |
3 |
WY-14643, WY14,643, Wy-14,643, Wy-14643, pirinixic acid |
| XBP1 |
gene |
3 |
2 |
X-box binding protein 1 |
| X chromosome |
drug |
9 |
3 |
Chromosome X, chromosome X |
| Xenopus laevis |
cohort |
3 |
1 |
Xenopus laevis, clawed frog |
| X-inactivation |
phenotype |
2 |
2 |
|
| XIST |
gene |
5 |
2 |
XIST gene |
| XRCC5 |
gene |
3 |
1 |
Ku80, KU80, XRCC5, XRCC5 ortholog |
| XRCC6 |
gene |
2 |
1 |
Ku70, XRCC6 |
| xylazine |
drug |
5 |
5 |
xylazine hydrochloride |
| xylene |
drug |
5 |
2 |
|
| Yale-Penn |
cohort |
14 |
7 |
Alcohol Dependence GWAS in European and African Americans, YP, Yale-Penn Study, Yale-Penn dataset, Yale-Penn discovery, Yale-Penn participants, Yale-Penn replication, Yale-Penn samples, Yale–Penn, phs000425.v1.p1 |
| Yale–Penn |
cohort |
3 |
1 |
|
| YalePenn |
cohort |
2 |
1 |
|
| Yale-Penn cohort |
cohort |
2 |
1 |
Yale-Penn |
| Yale–Penn cohort |
cohort |
2 |
1 |
Yale-Penn |
| Yale-Penn sample |
cohort |
4 |
1 |
|
| Yale-Penn study |
cohort |
3 |
— |
Yale-Penn |
